Login / Signup

Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.

Bryan P WhiteSmit PatelJanice TsuiDaniel B Chastain
Published in: Infectious diseases (London, England) (2019)
Clinicians should consider double carbapenem therapy as an option for treating CRE infections.
Keyphrases
  • klebsiella pneumoniae
  • acinetobacter baumannii
  • multidrug resistant
  • gram negative
  • palliative care
  • drug resistant
  • escherichia coli
  • stem cells
  • mesenchymal stem cells